Israeli startup clears FDA approval for advanced cancer imaging machine

Newly developed proton-based imaging solution allows for safer and more precise imaging of a patient's body; 'We truly believe this marks a new age of cancer imaging treatments,' says company CEO
Nina Fox|
The U.S. Federal Drug Administration (FDA) approved on Monday an Israeli-developed compact Proton Therapy system designed to provide cancer patients with focused treatment free of side effects.
<< Follow Ynetnews on Facebook and Twitter >>
Israeli startup P-Cure describes its solution as personalized cancer treatment, proton therapy enhancement. The large apparatus occupies several building floors and costs $50 million per unit.
2 View gallery
ד"ר פלדמן, פיזיקאי ראשי הדסה על רקע המערכת של פי-קיור
ד"ר פלדמן, פיזיקאי ראשי הדסה על רקע המערכת של פי-קיור
Dr. Feldman, head physician at Hadassah medical center, with the new imaging machine
At this stage, the treatment is only available to a few hundred hospitals worldwide, none of which are in Israel. The cost of the treatment is over $100,000 per patient, which has already compelled some Israelis to travel to Europe and the United States to obtain it.
This newly developed proton-based imaging solution allows for a safer and more precise imaging of a patient's body.
Protons are subatomic particles that enter the body and release energy upon colliding with cancerous cells or tissue. In contrast to X-ray treatment, proton treatment is more targeted and results in substantially less harmful radiation.
2 View gallery
X-Ray for cancer imaging might become obsolete
X-Ray for cancer imaging might become obsolete
X-Ray for cancer imaging might become obsolete
(Photo: Courtesy)
The Israeli company behind this innovative technology has a testing facility in the central Israeli city of Modi'in and has also established a facility in China in order to provide better access to the treatment for patients in the Far East.
P-Cure CEO Michael Marash said: "We truly believe this marks a new age of cancer imaging treatments."
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""